دورية أكاديمية

LBO09 - A phase 1b study of lenvatinib plus pembrolizumab in unresectable hepatocellular carcinoma.

التفاصيل البيبلوغرافية
العنوان: LBO09 - A phase 1b study of lenvatinib plus pembrolizumab in unresectable hepatocellular carcinoma.
المؤلفون: Finn, Richard (AUTHOR), Ikeda, Masafumi (AUTHOR), Zhu, Andrew (AUTHOR), Sung, Max W. (AUTHOR), Baron, Ari D. (AUTHOR), Kudo, Masatoshi (AUTHOR), Okusaka, Takuji (AUTHOR), Kobayashi, Masahiro (AUTHOR), Kumada, Hiromitsu (AUTHOR), Kaneko, Shuichi (AUTHOR), Pracht, Marc (AUTHOR), Mamontov, Konstantin (AUTHOR), Meyer, Tim (AUTHOR), Mody, Kalgi (AUTHOR), Kubota, Tomoki (AUTHOR), Dutcus, Corina E. (AUTHOR), Saito, Kenichi (AUTHOR), Siegel, Abby B. (AUTHOR), Dubrovsky, Leonid (AUTHOR), Llovet, Josep M. (AUTHOR)
المصدر: Journal of Hepatology. 2020 Supplement 1, Vol. 73, pS120-S121. 2p.
مصطلحات موضوعية: *HEPATOCELLULAR carcinoma, *PEMBROLIZUMAB
قاعدة البيانات: Academic Search Index
الوصف
تدمد:01688278
DOI:10.1016/S0168-8278(20)30758-3